These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3556959)

  • 21. Improved long-term survival following complete eradication of esophageal varices by sclerotherapy.
    Matsumoto H; Suzuki F; Souda K; Kitahara H; Kobayashi Y; Kawasaki T; Nakao K; Matsumoto M; Iwata K; Ohta Y; Kanai K
    Hepatogastroenterology; 1999; 46(25):172-6. PubMed ID: 10228784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.
    Masci E; Stigliano R; Mariani A; Bertoni G; Baroncini D; Cennamo V; Micheletti G; Casetti T; Tansini P; Buscarini E; Ranzato R; Norberto L
    Hepatogastroenterology; 1999; 46(27):1769-73. PubMed ID: 10430341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Esophageal cancer and endoscopic sclerosis of esophageal varices: a fortuitous association?].
    Guillemot F; Bonnière P; Bretagne JF; Ancelin JP; Raoul JL; Plane C; Cortot A; Paris JC
    Gastroenterol Clin Biol; 1988 Nov; 12(11):858-61. PubMed ID: 3220235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices.
    Lo GH; Lai KH; Cheng JS; Chen MH; Chiang HT
    Hepatology; 2001 May; 33(5):1060-4. PubMed ID: 11343232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
    Hong SN; Kim BJ; Lee SY; Lee CY; Ryu MK; Choi MS; Lee JH; Rhee PL; Koh KC; Kim JJ; Paik SW; Rhee JC; Choi KW
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):288-96. PubMed ID: 12499786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of Nissen-Rossetti fundoplication on the motor function of swallowing in patients with reflux diseases].
    Wallner G; Misiuna P; Dabrowski A; Abramowicz K; Polkowski W; Mijal M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():282-92. PubMed ID: 9446370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophageal function after sclerotherapy of bleeding varices.
    Sauerbruch T; Wirsching R; Leisner B; Weinzierl M; Pfahler M; Paumgartner G
    Scand J Gastroenterol; 1982 Sep; 17(6):745-51. PubMed ID: 6984219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stomach in portal hypertension.
    Amarapurkar DN; Dhawan PS; Chopra K; Shankaran K; Kalro RH
    J Assoc Physicians India; 1993 Oct; 41(10):638-40. PubMed ID: 8294322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.
    Nevens F; Broeckaert L; Rutgeerts P; Van Steenbergen W; Fevery J
    Hepatogastroenterology; 1995; 42(6):979-84. PubMed ID: 8847055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].
    Villanueva C; Martínez FJ; Torras X; Sáinz S; Soriano G; González D; Balanzó J
    Rev Esp Enferm Dig; 1994 Jul; 86(1):499-504. PubMed ID: 7917561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of laparoscopic nissen fundoplication with prosthetic hiatal closure on esophageal body motility: Results of a prospective randomized trial.
    Granderath FA; Kamolz T; Schweiger UM; Pointner R
    Arch Surg; 2006 Jul; 141(7):625-32. PubMed ID: 16847231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Manometric findings after sclerotherapy for esophageal varices].
    Arcidiaco M; Perricelli D; Turpini F; Poggi L; Arcelloni S
    Chir Ital; 1989; 41(4-6):213-22. PubMed ID: 2641732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal motility and symptoms after endoscopic injection sclerotherapy.
    Cohen LB; Simon C; Korsten MA; Scherl EJ; Skorniky J; Guelrud MB; Waye JD
    Dig Dis Sci; 1985 Jan; 30(1):29-32. PubMed ID: 3871190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of endoscopic variceal sclerotherapy on esophageal motor functions and gastroesophageal reflux.
    Sidhu SS; Bal C; Karak P; Garg PK; Bhargava DK
    J Nucl Med; 1995 Aug; 36(8):1363-7. PubMed ID: 7629578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal motility: effects of injection sclerotherapy.
    Larson GM; Vandertoll DJ; Netscher DT; Polk HC
    Surgery; 1984 Oct; 96(4):703-10. PubMed ID: 6484810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of esophageal variceal sclerotherapy (EVS) on lung function. A prospective controlled study.
    Korula J; Baydur A; Sassoon C; Sakimura I
    Arch Intern Med; 1986 Aug; 146(8):1517-20. PubMed ID: 3524493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oesophageal function in cirrhotic patients undergoing injection sclerotherapy for oesophageal varices.
    Ogle SJ; Kirk CJ; Bailey RJ; Johnson AG; Williams R; Murray-Lyon IM
    Digestion; 1978; 18(3-4):178-85. PubMed ID: 33094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in the esophageal wall following sclerotherapy of varices--roentgen morphology and therapy].
    Brambs HJ; Billmann P; Hoppe-Seyler P; Büchsel R
    Radiologe; 1985 Nov; 25(11):525-8. PubMed ID: 4089167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal motility changes after endoscopic intravariceal sclerotherapy with absolute alcohol.
    Ghoshal UC; Dhar K; Chaudhuri S; Pal BB; Pal AK; Banerjee PK
    Dis Esophagus; 2000; 13(2):148-51. PubMed ID: 14601907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of esophageal motility after its resection and extensive devascularization].
    Draczkowski T; Zadrozny D; Oledzki M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():313-7. PubMed ID: 9446375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.